ライフサイエンスコーパス: BHT

1 BHT and alpha-tocopherol showed lower antioxidant activi

2 BHT binding also changes the g-tensor components of the

3 BHT prevented the inhibition of TNFalpha on glutamate tr

4 BHT-3009 is a tolerizing DNA vaccine for MS, encoding fu

5 organoaluminum compounds such as MeAl(BHT)2 (BHT = 2,6-di-tert-butyl-4-methylphenolate) in hydrocarbo

6 phrine (PE, alpha(1) selective) and BHT-933 (BHT, alpha(2) selective) were administered intra-arteria

7 occurred via covalent functionalization of a BHT-derivative directly to the SWCNT sidewall, the amoun

8 actions of the existing pendant sites with a BHT derivative, the amount of BHT-derivative loading pro

9 antly different in the microcosms with added BHT (k = 0.001 h(-1)).

10 s in a manner similar to that observed after BHT.

11 epinephrine or the alpha2-adrenergic agonist BHT 920 also caused dose-dependent increases in nitrite

12 kg min) and an alpha-adrenoreceptor agonist, BHT-933 (1.0 to 10 mug kg min) during normothermia and p

13 iodegradation of the oil was observed at all BHT concentrations and was significant in the microcosms

14 ed doses of PE (0.3 microg kg(-1) l(-1)) and BHT (15 microg kg(-1) l(-1)) were administered at rest a

15 PE (0.8 microg kg(-1)) and BHT (40 microg kg(-1)) produced comparable maximal reduc

16 he doses, PE (1.6 microg kg(-1) min(-1)) and BHT (80 microg kg(-1) min(-1)) caused significantly smal

17 ading of 333 gal acre(-1) (0.31 L m(-2)) and BHT concentrations ranging from 0 to 800 mg kg(-1) (0, 5

18 sponse (anodic peak current, Ipa) of BHA and BHT by 2- and 20-times, respectively.

19 was inhibited by heme poisons, catalase, and BHT.

20 cal perfusion with quinpirole, 7-OH-DPAT and BHT-920 into the globus pallidus/putamen also produced a

21 oaminergic agonist quinpirole, 7-OH-DPAT and BHT-920, into the ventral tegmental area produced a dose

22 (+)-catechin, (-)-epicatechin, EGC, EGCG and BHT.

23 mount of alcohol, the synergy is exalted and BHT regenerates twice as much alpha-tocopherol due to a

24 , namely 250, 500, 1000 and 2000microg/g and BHT standard at 200microg/g.

25 ineffective in the RPMI7932, PCF-2, LM, and BHT-101 cell lines expressing low levels of B7h.

26 ssays showed that both nonfunctionalized and BHT-derivatized SWCNTs have little or no deleterious eff

27 Infusion of PE and BHT-933 resulted in greater absolute decreases in FVC du

28 s phenylephrine (PE, alpha(1) selective) and BHT-933 (BHT, alpha(2) selective) were administered intr

29 x) and two hydrophobic (alpha-tocopherol and BHT) antioxidants were measured by reaction with a serie

30 traction (CE) extracts, alpha-tocopherol and BHT, respectively, as compared to the control (EVOO with

31 in ORAC assay more than alpha-tocopherol and BHT.

32 r effectiveness as the synthetic antioxidant BHT to inhibit lipid peroxidation.

33 g, higher than that of synthetic antioxidant BHT.

34 ith that showed by the synthetic antioxidant BHT.

35 nted with seaweed extracts than antioxidants BHT and alpha-tocopherol (<5h and <17, respectively).

36 orms such classical phenolic antioxidants as BHT and probucol and rivals the antioxidant potency of V

37 multiplex detection and measurement of BHA, BHT, and TBHQ levels in complex food samples using a lin

38 oluble and nonaggressive sodium salt of BHT (BHT=2,6-di-tert-butyl-hydroxytoluene), both six- and fiv

39 roxymethyl BHT (1) and 3-hydroxy- tert-butyl BHT (2).

40 The antioxidant t-butylhydroxytoluene (BHT, 1%) was mixed with the HC diet in the last 3 weeks.

41 BHT and OR during storage in the air, and by BHT in vacuum-packaged samples.

42 tas of HC rabbits, where it was decreased by BHT, and it was also detected in the aortas of atheroscl

43 aortic SERCA activity in HC was restored by BHT without changing SERCA protein expression.

44 duced relaxation, and these were restored by BHT.

45 ly) that are increased 12-26-fold by chronic BHT administration.

46 ng tumors unless this is followed by chronic BHT exposure.

47 stability, more than oil samples containing BHT.

48 ated with a single layer or few layers of Cu-BHT.

49 benzenehexathiolate coordination polymer (Cu-BHT) has been prepared.

50 five different diets: control (basal diet); BHT (basal diet with 200mgkg(-1) of butylated hydroxytol

51 c tocopherols>green tea extract>sinapic acid>BHT.

52 ter>hexyl esterdodecyl ester>octadecyl ester>BHT while the order for the BCB anti-oxidative activity

53 relationship of isochromans compared to HT, BHT and alpha-tocopherol.

54 ely converted to two products, hydroxymethyl BHT (1) and 3-hydroxy- tert-butyl BHT (2).

55 xpensive 3,5-di-tert-butyl-4-hydroxytoluene (BHT, 1) as a starting material.

56 ntioxidant 2,6-di-tert-butyl-hydroxytoluene (BHT) at 20 and 800ppm was tackled.

57 at of 100 mg/kg of butylated hydroxytoluene (BHT) and alpha-tocopherol in the Rancimat test at 50-70

58 to ROs containing butylated hydroxytoluene (BHT) and an extra virgin olive oil (EVOO) with a high po

59 roxyanisole (BHA), butylated hydroxytoluene (BHT) and tert-butyl hydroquinone (TBHQ), were determined

60 The antioxidant butylated hydroxytoluene (BHT) and the NF kappa B inhibitor PTD-p65 peptide inhibi

61 and compared with butylated hydroxytoluene (BHT) as reference compound.

62 gallate (EGCG) and butylated hydroxytoluene (BHT) correlate with structural changes of phosphatidylch

63 ty to 0.26 mg/g of butylated hydroxytoluene (BHT) in the linoleic acid emulsions.

64 We used butylated hydroxytoluene (BHT) lung injury to demonstrate that premature expressio

65 cholanthrene (MCA)/butylated hydroxytoluene (BHT) lung tumor initiation/promotion protocol.

66 ts, vitamin E, and butylated hydroxytoluene (BHT) markedly inhibited necrosis induced by APAP or DEM

67 Chronic butylated hydroxytoluene (BHT) treatment after a single administration of a carcin

68 anthrene (MCA) and butylated hydroxytoluene (BHT) was used to induce lung tumorigenesis.

69 y extract (OR) and butylated hydroxytoluene (BHT) were added individually and in mixture (MIX) to raw

70 pha-tocopherol and Butylated hydroxytoluene (BHT) were evaluated using chemical assays, 2,2-diphenyl-

71 roxyanisole (BHA), butylated hydroxytoluene (BHT), and tert-butylhydroquinone (TBHQ) are synthetic an

72 zphetamine (BZ) or butylated hydroxytoluene (BHT), the latter representing a substrate capable of ind

73 tumor promotion by butylated hydroxytoluene (BHT), we hypothesized that hyperplastic compensatory lun

74 hetic antioxidant, butylated hydroxytoluene (BHT).

75 se to those of the butylated hydroxytoluene (BHT).

76 , sinapic acid and butylated hydroxytoluene (BHT).

77 hetic antioxidant, butylated hydroxytoluene (BHT).

78 tioxidants such as butylated hydroxytoluene (BHT).

79 to that of 1mM of butylated hydroxytoluene (BHT).

80 nolic antioxidant, butylated hydroxytoluene (BHT).

81 t bound substrate [butylated hydroxytoluene (BHT)] and radiolytically one-electron cryoreduced at 77

82 methylcholanthrene/butylated hydroxytoluene (BHT; 3,5-di-t-butyl-4-hydroxytoluene) tumor initiation/p

83 udy, the effect of butylated-hydroxytoluene (BHT) on the biodegradation of glyceryl trilinoleate, a m

84 te of the hydrolytic process was observed in BHT samples.

85 mpared to 7 synthetic antioxidants including BHT, BHA, TBHQ and PG with regard to their ability to pr

86 d not significantly increase with increasing BHT concentrations.

87 dely used antioxidants in the food industry, BHT, alpha-tocopherol, and dodecyl gallate.

88 owing order: green tea<yellow tea<blackberry<BHT<cranberry<lemon<oil without additives.

89 separate tumor initiator/promoter model (MCA+BHT) indicated that NF-kappaB functions as an independen

90 This low-dose MCA/BHT model in BALB mice will facilitate the identificatio

91 Tumors from MCA/BHT-treated Rosa26-Foxm1 mice displayed a significant in

92 Kinetics of the polymerization by the 3/MeAl(BHT)2 pair suggest a bimolecular, activated-monomer anio

93 rization can be achieved by using the 3/MeAl(BHT)2 propagator/catalyst pair, which is conveniently ge

94 lizing organoaluminum compounds such as MeAl(BHT)2 (BHT = 2,6-di-tert-butyl-4-methylphenolate) in hyd

95 by in situ mixing of 2 with 2 equiv of MeAl(BHT)2.

96 alogue that generates less of the metabolite BHT-quinone methide (2,6-di-tert-butyl-4-methylene-2,5-c

97 erved with 2,6-di-tert-butyl-4-methylphenol (BHT).

98 ring weeks 8 to 48 was 61% lower with 0.5 mg BHT-3009 (p = 0.05).

99 ing weeks 28 to 48 was 50% lower with 0.5 mg BHT-3009 (p = 0.07) and during weeks 8 to 48 was 61% low

100 myelin-specific autoantibodies in the 0.5 mg BHT-3009 arm were observed, but not with placebo or 1.5

101 g lesions at week 48 was 51% lower on 0.5 mg BHT-3009 compared with placebo (p = 0.02).

102 groups: placebo, 0.5 mg BHT-3009, or 1.5 mg BHT-3009, given intramuscularly at weeks 0, 2, 4, and ev

103 zed 1:1:1 into three groups: placebo, 0.5 mg BHT-3009, or 1.5 mg BHT-3009, given intramuscularly at w

104 g lesion parameters was observed with 1.5 mg BHT-3009.

105 ere observed, but not with placebo or 1.5 mg BHT-3009.

106 PE: 3.7 +/- 0.4 vs. 2.0 +/- 0.3 ml min mmHg; BHT-933: 3.8 +/- 0.2 vs. 2.1 +/- 0.3 ml min mmHg; P < 0.

107 PE: 7.8 +/- 1.1 vs. 2.8 +/- 0.5 ml min mmHg; BHT-933: 8.6 +/- 1.7 vs. 2.1 +/- 0.4 ml min mmHg; P < 0.

108 il was mineralized in the microcosms with no BHT.

109 owing PE (-16 +/- 5 and -16 +/- 4%), but not BHT (-2 +/- 4 and -4 +/- 5%).

110 nate complexes such as Li+[Me2C=C(OiPr)OAlMe(BHT)2]- (3).

111 t sites with a BHT derivative, the amount of BHT-derivative loading proportionately increased the ove

112 irectly to the SWCNT sidewall, the amount of BHT-derivative loading was inversely proportional to the

113 hers, such as the lipophilic antioxidants of BHT and alpha-Tocopherol did not show any activity.

114 y in MCA-treated mice given one injection of BHT (200 mg/kg body weight) increased significantly (P <

115 size in mice given one or two injections of BHT were comparable to those in animals subjected to PNX

116 s, treatment with the lower dose (0.5 mg) of BHT-3009 for 44 weeks nearly attained the primary end po

117 s most effectively inhibited by a mixture of BHT and OR during storage in the air, and by BHT in vacu

118 nnealing contains an enzyme-bound product of BHT monooxygenation.

119 the soluble and nonaggressive sodium salt of BHT (BHT=2,6-di-tert-butyl-hydroxytoluene), both six- an

120 antioxidant activities comparable to that of BHT, and stronger radical scavenging activities and high

121 siveness of CalfBF or CalfVC to either PE or BHT-933.

122 C-MS/MS) analysis shows that in this process BHT is quantitatively converted to two products, hydroxy

123 ype monocytes to macFoxm1(-/-) mice restored BHT-induced pulmonary inflammation to the levels observe

124 nds were detected in several of the samples, BHT being the most frequently found.

125 Both techniques showed BHT to be efficient in limiting oxidation reactions duri

126 se linearly (R2 = 0.99) with each subsequent BHT injection.

127 mpare pairs of trees (Bayes hypothesis test, BHT), or test each tree against an average of the trees

128 f low-molecular-weight aldehydes better than BHT and with similar results to the EVOO.

129 values of HBMe was significantly lower than BHT, and metal chelating ability of HBMe also showed a s

130 Lower bacteria counts were observed for the BHT and thymol groups, in addition to a slower deteriora

131 cleophilic addition of short alcohols on the BHT oxidation product, giving a new phenolic co-antioxid

132 Based on two data sets, the BHT and BST are shown to construct similar confidence se

133 tself is a better radical scavenger than the BHT-derivatized SWCNT.

134 henols have been designed as alternatives to BHT and BHA antioxidants.

135 ar and non protic solvents, such as toluene, BHT regenerates alpha-tocopherol from tocopheryl radical

136 tyl and 4-methyl (butylated hydroxy toluene, BHT), 4-ethyl, or 4-methoxy methylene substituents yield

137 der for the BCB anti-oxidative activity was; BHT>octadecyl ester>dodecyl ester>hexyl ester>methyl est

138 Only one species is observed when BHT is bound, indicating a more ordered active site.

139 OR added alone or in combination with BHT maintained the quality of turkey meatballs during fr

140 ho were administered feeds supplemented with BHT, carvacrol and (to a lesser degree) rosemary.

141 ons (100 MPa) and acted synergistically with BHT in increasing the stability of lycopene nanoemulsion